BA
GH icon

Bridgewater Associates’s Guardant Health GH Stock Holding History

Bridgewater Associates’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$637K Sell
4,244
-9,107
-68% -$990K ﹤0.01% 893
2026
Q1 		$1.23M Sell
13,351
-14,940
-53% -$1.5M 0.01% 758
2025
Q4 		$2.89M Buy
28,291
+24,281
+606% +$2.17M 0.01% 682
2025
Q3 		$251K Buy
4,010
+140
+4% +$7.62K ﹤0.01% 985
2025
Q2 		$201K Sell
3,870
-1,200
-24% -$53.6K ﹤0.01% 579
2025
Q1 		$216K Sell
5,070
-7,474
-60% -$322K ﹤0.01% 642
2024
Q4 		$383K Sell
12,544
-5,596
-31% -$157K ﹤0.01% 602
2024
Q3 		$416K Sell
18,140
-2,061
-10% -$58.3K ﹤0.01% 706
2024
Q2 		$583K Sell
20,201
-87,615
-81% -$2.04M ﹤0.01% 736
2024
Q1 		$2.22M Buy
107,816
+72,699
+207% +$1.56M 0.01% 481
2023
Q4 		$950K Sell
35,117
-1,907
-5% -$50K 0.01% 640
2023
Q3 		$1.1M Buy
37,024
+1,675
+5% +$58.9K 0.01% 592
2023
Q2 		$1.27M Sell
35,349
-86
-0.2% -$2.47K 0.01% 546
2023
Q1 		$831K Sell
35,435
-93,111
-72% -$2.66M 0.01% 580
2022
Q4 		$3.5M Sell
128,546
-30,917
-19% -$1.41M 0.02% 427
2022
Q3 		$8.58M Sell
159,463
-3,015
-2% -$155K 0.04% 273
2022
Q2 		$6.55M Buy
162,478
+19,437
+14% +$963K 0.03% 424
2022
Q1 		$9.47M Buy
143,041
+37,888
+36% +$2.59M 0.04% 311
2021
Q4 		$10.5M Buy
105,153
+1,195
+1% +$124K 0.06% 184
2021
Q3 		$13M Sell
103,958
-4,802
-4% -$571K 0.07% 168
2021
Q2 		$13.5M Buy
108,760
+42,114
+63% +$5.66M 0.09% 178
2021
Q1 		$10.2M Buy
66,646
+10,279
+18% +$1.55M 0.09% 160
2020
Q4 		$7.26M Buy
56,367
+32,496
+136% +$3.74M 0.06% 156
2020
Q3 		$2.67M Buy
+23,871
New +$2.18M 0.03% 220

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Bridgewater Associates's GH Position: Q2 2026 in Review

Bridgewater Associates reduced its Guardant Health (GH) stake by 68% in Q2 2026, selling an estimated $990K and leaving 4,244 shares worth $637K. The position accounts for ﹤0.01% of the portfolio, ranked #893.

Bridgewater Associates first reported a position in GH in Q3 2020 and has held it in 24 quarters since. The position peaked at $13.5M in Q2 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Bridgewater Associates held 4,244 shares of Guardant Health worth $637K as of Q2 2026.
  • Bridgewater Associates sold 9,107 Guardant Health shares in Q2 2026, an estimated $990K.
  • Guardant Health made up ﹤0.01% of Bridgewater Associates's portfolio in Q2 2026, its #893 holding.
  • Bridgewater Associates first reported a position in Guardant Health in Q3 2020 and has held it in 24 quarters since.
  • Bridgewater Associates's Guardant Health position peaked at $13.5M in Q2 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.